4//SEC Filing
Sherman Matthew L 4
Accession 0000950170-24-005393
CIK 0001654151other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:15 PM ET
Size
4.7 KB
Accession
0000950170-24-005393
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-16$14.47/sh−2,435$35,234→ 94,079 total
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001325710
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:15 PM ET
- Size
- 4.7 KB